Mitochondrial involvement in chronic chagasic cardiomyopathy

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 5, 2011, Pages 239-246

  Báez, Alejandra ^a,b,c   Presti, María Silvina Lo ^c,d   Rivarola, Héctor Walter ^c   Mentesana, Gustavo Guzmán ^c   Pons, Patricia ^c   Fretes, Ricardo ^c   Paglini Oliva, Patricia ^c  

^a Universidad Nacional de La Rioja   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Argentina; Chagas disease; Chronic chagasic cardiopathy; Mitochondria; Trypanosoma cruzi

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CHRONIC CHAGASIC CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART MUSCLE; HISTOPATHOLOGY; INFLAMMATION; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PARASITEMIA; SKELETAL MUSCLE; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 79955026292     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.01.007     Document Type: Article

References (37)

1. Pereira Silva C., Del Carlo C.H., Tavares de Oliveira M., Scipioni A., Strunz Cassaro C., Franchini Ramírez J.A., et al. Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?. Arq Bras Cardiol 2008, 91:358-362.
2. WHO Expert committee on the control of Chagas disease 2007, World Health Organization, Geneva.
3. Carod-Artal F.J., Gascon J. Chagas disease and stroke. Lancet Neurol 2010, 9:533-542.
4. Cunha Neto E., Nogueira L.G., Teixeira P.C., Ramasawmy R., Drigo S.A., Goldberg A.C., et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 2009, 104:252-258.
5. Sousa L., Botoni F.A., Britto R.R., Rocha M.O., Teixeira A.L., Reis A.M., et al. Six-minute walk test in Chagas cardiomyopathy. Int J Cardiol 2008, 125:139-141.
6. Milei J., Storino R., Fernandez Alonso G., Beigelman R., Vanzulli S., Ferrans V.J. Endomyocardial biopsies in chronic chagasic cardiomyopathy. Immunohistochemical and ultrastructural findings. Cardiology 1992, 80:424-437.
7. Higuchi M., de L., Gutierrez P.S., Aiello V.D., Palomino S., Bocchi E., Kalil J., et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993, 423:157-160.
8. Benvenuti L.A., Roggério A., Freitas H.F., Mansur A.J., Fiorelli A., Higuchi M.L. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008, 102:481-487.
9. Ferreira R.C., Ianni B.M., Abel L.C., Buck P., Mady C., Kalil J., et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/'indeterminate' and Chagas disease cardiomyopathy patients. Mem Inst. Oswaldo Cruz 2003, 98:407-411.
10. Talvani A., Rocha M.O., Barcelos L.S., Gomes Y.S., Ribeiro A.L., Teixeira M.M. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004, 38:943-950.
11. Cardoni M.I., Antunez C., Morales I., Nantes R. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1997, 56:329-334.
12. López L., Arai K., Giménez E., Jiménez M., Pascuzo C., Rodríguez-Bonfante C., et al. Las concentraciones séricas de interleucina-6 y proteína c reactiva se incrementan a medida que la enfermedad de Chagas evoluciona hacia el deterioro de la función cardiac [in Spanish]. Rev Esp Cardiol 2006, 59:50-56.
13. Kanda T., Takahashi T. Interleukin-6 and cardiovascular diseases. Jap Heart J 2004, 45:183-193.
14. Marin-García J., Goldenthal M.J. Mitochondrial centrality in heart failure. Heart Fail Rev 2008, 13:137-150.
15. Tsutsi H. Oxidative stress in heart failure: the role of mitochondria. Intern Med 2006, 40:1177-1182.
16. Báez A.L., Lo Presti M.S., Rivarola H.W., Pons P., Fretes R., Paglini-Oliva P. Trypanosoma cruzi: cardiac mitochondrial alterations produced by different strains in the acute phase of the infection. Exp Parasitol 2008, 120:397-402.
17. Garg N., Popov V.L., Papaconstantinou J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implication in chagasic myocarditis development. Biochem Biophys Acta 2003, 1638:106-120.
18. Bustamante J.M., Rivarola H.W., Fernández A.R., Enders J.E., Ricardo F., d'Oro Gloria D.L., et al. Trypanosoma cruzi reinfections provoke synergistic effect and cardiac beta-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease. Exp Parasitol 2003, 103:136-142.
19. Bustamante J.M., Rivarola H.W., Fernández A.R., Enders J.E., Fretes R., Palma J.A., et al. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Clin Sci (Lond) 2003, 104:415-420.
20. Vyatkina G., Bhatia V., Gerstner A., Papaconstantinou J., Garg N. Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochem Biophys Acta 2004, 1689:162-173.
21. National Institutes of Health. Guide for the care and use of laboratory animals (NIH publication number 85-23). Bethesda: NIH; 1996.
22. Enders J.E., Fernandez R., Rivarola H.W., Paglini-Oliva P., Palma J.A. Studies of membrane fluidity and heart contractile force in Trypanosoma cruzi infected mice. Mem Inst Oswaldo Cruz 2004, 99:691-696.
23. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Meth Enzymol 1996, 264:484-509.
24. Jarreta D., Orus J., Barrientos A., Miro O., Roig E., Heras M., et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 2000, 45:860-865.
25. Bradford M.A. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-DNA binding. Ann Biochem 1976, 72:248-254.
26. Omura T., Yoshiyama M., Hayashi T., Nishiguchi S., Kaito M., Horiike S., et al. Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 2005, 96:148-150.
27. Soriano F.G., Nogueira A.C., Caldini E.G., Lins M.H., Teixeira A.C., Cappi S.B., et al. Potential role of poly (adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit Care Med 2006, 4:1073-1079.
28. Marín-García J., Goldenthal M.J. The mitochondrial organelle and the heart [in Spanish]. Rev Esp Cardiol 2002, 55:1293-1310.
29. Theleman K.F., Nuipper J.J., Roberts W.C. Acute myocarditis sudden death without heart failure. Am J Cardiol 2001, 88:1078-1083.
30. Brady W.J., Ferguson J.D., Ullman E.A., Perron A.D. Myocarditis: emergency department recognition and management. Emerg Med Clin N Am 2004, 22:865-885.
31. Wen J.J., Garg N. Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Rad Biol Med 2004, 37:2072-2081.
32. Wen J.J., Vyatkina G., Garg N. Oxidative damage during chagasic cardiomyopathy development: role of the mitochondrial oxidant release and inefficient antioxidant defense. Free Rad Biol Med 2004, 37:1821-1833.
33. Guzmán Mentesana G., Baez A., Domínguez R., Córdoba R., Comay D., Lo Presti S., et al. Structural and funtional alterations of cardiac and skeletal muscle mitochondria in patients with congestive heart failure. Circulation 2008, 127:699.
34. Wen J.J., Bhatia V., Popov V.L., Garg N.J. Pheyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am J Pathol 2006, 169:1953-1964.
35. Manoel-Caetano S.F., Silva A.E. Implication of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad Saúde Pública 2007, 23:2263-2274.
36. Bilate A.M., Cunha Neto E. Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo 2008, 50:67-74.
37. Lauria-Pires L, Bogliolo AR, Texeira ARL. Diversity of Trypanosoma cruzi stocks and clones derived from Chagas disease patients.II: Isozyme and RFLP characterizations. Exp Parasitol 1996;82:182-90.